Approval · Notice of Compliance 12314 · 2011
DUODOPA: Notice of Compliance 12314
Issued May 6, 2011
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 12314
- Date
- May 6, 2011
- Company
- Abbott Laboratories Co.Saint-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Change in manufacturer name
- Therapeutic class
- Antiparkinson agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DUODOPA | 02292165 | Marketed |
Medicinal ingredients
- LEVODOPA 20 MG per ML
- CARBIDOPA MONOHYDRATE 5 MG per ML